Malvern (Pennsylvania) [US], May 23 (ANI): Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold on the Company's Phase 2, 3 clinical trials for COVAXIN™ (BBV152).
New Delhi [India], June 6 (ANI): The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown COVID-19 vaccine, Bharat Biotech's Covaxin, from Monday, sources said.
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
New Delhi [India], July 24 (ANI): The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country's first indigenous vaccine candidate `Covaxin' to a 30-year-old man as part of efforts to combat COVID-19.